Cubist Systematic Strategies’s Indivior Pharmaceuticals INDV Stock Holding History

Cubist Systematic Strategies’s Portfolio INDV Stock Details INDV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$8.56M	Buy	+355,245	New	+$7.43M	0.04%	648
2025 Q2	–	Sell	-7,767	Closed	-$74K	–	3240
2025 Q1	$74K	Sell	7,767 -211,191	-96%	-$2.22M	﹤0.01%	2672
2024 Q4	$2.72M	Buy	+218,958	New	+$2.25M	0.02%	1177
2024 Q3	–	Sell	-25,236	Closed	-$407K	–	3224
2024 Q2	$407K	Buy	25,236 +6,121	+32%	+$110K	﹤0.01%	2225
2024 Q1	$409K	Buy	+19,115	New	+$359K	﹤0.01%	2734

Other funds holding INDV

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Cubist Systematic Strategies's INDV Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Indivior Pharmaceuticals (INDV) in Q3 2025: 355,245 shares worth $8.56M. The stake represents 0.04% of the portfolio and ranks #648 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in INDV as recently as Q1 2025.

Cubist Systematic Strategies first reported a position in INDV in Q1 2024 and has held it in 5 quarters since. 198 funds tracked by Wall St. Rank hold INDV as of Q3 2025.

Cubist Systematic Strategies held 355,245 shares of Indivior Pharmaceuticals worth $8.56M as of Q3 2025.
Indivior Pharmaceuticals was a new Cubist Systematic Strategies position in Q3 2025.
Indivior Pharmaceuticals made up 0.04% of Cubist Systematic Strategies's portfolio in Q3 2025, its #648 holding.
Cubist Systematic Strategies first reported a position in Indivior Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
198 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.